Long-Term Benefit from Adjuvant Tamoxifen in Luminal A and Luminal B Breast Cancer Patients

被引：0
|
作者：
Dar, Huma
Johansson, Annelie
Nordenskjold, Anna
Perez-Tenorio, Gizeh
Yau, Christina
Benz, Christopher C.
Esserman, Laura J.
Nordenskjold, Bo
Stal, Olle
Fornander, Tommy
Lindstrom, Linda S.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P2-03-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-03-04
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Is Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer?
    Coates, Alan S.
    Colleoni, Marco
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) : 1260 - 1263
  • [32] Waiting for Godot: Predictive factors for adjuvant treatment of patients with luminal breast cancer
    Di Cosimo, Serena
    Bregni, Giacomo
    Daidone, Maria Grazia
    Cinquini, Michela
    de Braud, Filippo
    Torri, Valter
    BREAST, 2016, 27 : 187 - 188
  • [33] LONG-TERM TAMOXIFEN ADJUVANT THERAPY IN NODE POSITIVE BREAST-CANCER - REPLY
    TORMEY, DC
    JORDAN, VC
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 149 - 150
  • [34] GYNECOLOGIC COMPLICATIONS ASSOCIATED WITH LONG-TERM ADJUVANT TAMOXIFEN THERAPY FOR BREAST-CANCER
    WOLF, DM
    JORDAN, VC
    GYNECOLOGIC ONCOLOGY, 1992, 45 (02) : 118 - 128
  • [35] Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer
    Yoruker, Ebru Esin
    Aydogan, Fatma
    Gezer, Ugur
    Saip, Pinar
    Dalay, Nejat
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 954 - 958
  • [36] Long-term outcome of patients with luminal A breast cancer surrogate subtype according to chromosomal instability measured by securin expression
    Plavetic, N. Dedic
    Lovric, M.
    Majzec, M.
    Kulic, A.
    Sirotkovic-Skerlev, M.
    Vrbanec, D.
    Podolski, P.
    Silovski, T.
    Jakic-Razumovic, J.
    BREAST, 2019, 44 : S102 - S103
  • [37] Failure Patterns of Luminal B Breast Cancer Following Postoperative Adjuvant Radiation Therapy
    Choi, N.
    Lee, S. W.
    Lim, Y.
    Eom, K. Y.
    Kang, E. Y.
    Kim, E. K.
    Kim, Y. J.
    Kim, J. H.
    Park, S. Y.
    Kim, I. A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S341 - S342
  • [38] Different Treatment Benefit for Luminal A and Luminal B Advanced Breast Cancinomas Receiving Aromatase Inhibitors.
    Ruiz-Borrego, M.
    Moreno, A.
    Salvador, J.
    Carabantes, F.
    Torregrosa, M. D.
    Olmos, T.
    Martinez, J.
    de la Haba, J.
    Valero, M.
    Martinez, F.
    Santaballa, A. M.
    Hernandez, R.
    Murias, A.
    Tortorella, A.
    Guzman, C.
    Palacios, J.
    CANCER RESEARCH, 2009, 69 (24) : 812S - 812S
  • [39] Failure Patterns of Luminal B Breast Cancer Following Postoperative Adjuvant Radiation Therapy
    Choi, N.
    Lee, S. W.
    Lim, Y.
    Eom, K. Y.
    Kang, E. Y.
    Kim, E. K.
    Kim, Y. J.
    Kim, J. H.
    Park, S. Y.
    Kim, I. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E9 - E10
  • [40] The molecular profile of luminal B breast cancer
    Creighton, Chad J.
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 289 - 297
12345